Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
Condition: Insulinoma Patients Interventions: Drug: Exenatide; Drug: 0.9% saline solution Sponsors: University Hospital, Basel, Switzerland; Gottfried und Julia Bangerter-Rhyner-Stiftung Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
Condition: Endogenous Hyperinsulinism Interventions: Drug: Exenatide; Drug: 0.9% saline solution Sponsors: University Hospital, Basel, Switzerland; Gottfried und Julia Bangerter-Rhyner-Stiftung Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
Condition: Insulinoma Patients Interventions: Drug: Exenatide; Drug: 0.9% saline solution Sponsors: University Hospital, Basel, Switzerland; Gottfried und Julia Bangerter-Rhyner-Stiftung Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2021 Category: Research Source Type: clinical trials
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
Conditions: Hypopituitarism; Central Diabetes Insipidus; Panhypopituitarism; Psychological Disorder; Social Isolation; Hypothalamic Diseases; Pituitary Diseases; Oxytocin Deficiency Interventions: Drug: Experimental: GLP1-RA (exenatide) administration; Drug: Control: Placebo administration Sponsors: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Instituto de Salud Carlos III Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2021 Category: Research Source Type: clinical trials
